The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / U.S. Antitrust Officials Poised to Block Anthem, Aetna Deals

U.S. Antitrust Officials Poised to Block Anthem, Aetna Deals

July 21, 2016 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters)—U.S. antitrust officials are poised to file lawsuits to block Anthem Inc’s acquisition of Cigna Corp., as well as Aetna Inc.’s takeover of Humana Inc., a person familiar with the matter tells Reuters.

You Might Also Like
  • U.S. Regulators Sue to Block Anthem-Cigna & Aetna-Humana Mergers
  • U.S. Justice Department Has Concerns about Aetna-Humana Deal
  • U.S. Hospitals Urge DOJ Antitrust Probe of Anthem-Cigna Deal

Antitrust regulators have been scrutinizing the deals and looking at the potential for higher prices if the insurance market consolidates so that Anthem, Aetna and UnitedHealth Group Inc., which is not involved in these deals, are the last three national health insurers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Skepticism that the Anthem-Cigna deal would pass muster has been high for most of that review process, but investors were betting that the Aetna-Humana combination was less troublesome and could be approved if the companies sold some assets.

The department’s decision could be announced by the end of next week, the source familiar with the matter added.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bloomberg first reported that the U.S. Justice Department had decided to sue to block the mergers.

Anthem, Cigna and Aetna declined to comment. Humana and the Justice Department were not immediately available for comment.

The two deals were announced about a year ago just weeks apart. Anthem officials said in May that the Justice Department was particularly concerned about its national large-employer business. Analysts have said it would be difficult to sell assets to meet those concerns.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Aetna’s purchase of Humana would combine two of the largest providers of Medicare Advantage plans for elderly people. Sources have told Reuters that the companies had presented a divestment plan and the names of possible buyers to the Justice Department less than two weeks ago.

Leerink Partners analyst Ana Gupte says in a research note that she expects the companies to fight the Department of Justice, but that Anthem’s and Cigna’s chances of success were slim.

She says she expects Humana and Cigna to use their strong cash positions to buy back shares or make small acquisitions. WellCare Health Plans, Molina Healthcare Inc and Centene Corp are possible targets, she said, though only WellCare is potentially open to a deal.

Filed Under: Legal Tagged With: Anthem Inc., Cigna Corp., Department of Justice, Health Insurance, merger

You Might Also Like:
  • U.S. Regulators Sue to Block Anthem-Cigna & Aetna-Humana Mergers
  • U.S. Justice Department Has Concerns about Aetna-Humana Deal
  • U.S. Hospitals Urge DOJ Antitrust Probe of Anthem-Cigna Deal
  • California Insurance Commissioner Urges U.S. to Block Anthem-Cigna Deal

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)